v3 Template
C

Cuprina Holdings Cayman Limited

Biomedical and Biotechnology Singapore ~40 employees
Founded
--
Employees (Est.)
~40
4 leaders known
Total Funding
$49.8M
Funding Rounds
4
Last Funding
2025-05-08

About Cuprina Holdings Cayman Limited

Cuprina Holdings is a Singapore-based biomedical and biotechnology company focused on developing and commercializing innovative products for chronic wound management and cosmeceuticals for the health and beauty sector.

Products & Services

MEDIFLY:A range of products for maggot debridement therapy (MDT) to clean non-healing wounds, offering options like MEDIFLY Free Range and MEDIFLY Baggots. Proven to be faster and more effective than conventional methods, with a limb salvage rate of 90.9%.
ANURAN Collagen:A collagen-based wound care product that acts as a scaffold and biochemical pathway to recruit fibroblasts post-debridement.
MEND Skin Restoration Balm:A hydrating balm developed with Full Crimp Milk LLP, targeted at sports enthusiasts for skin restoration.
Activ Labs Range:A range of cosmeceutical products for energy and general relief, specifically designed for athletes.

Specialties

Chronic Wound Management Maggot Debridement Therapy (MDT) Collagen Wound Care Cosmeceuticals

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: IPO
T: -
FT: IPO
A: 13800000
MR: -
FA: $13,800,000
FAN: 13800000
D: 2025-05-08
FD: 2025-05-08
1 investors
2 RT: IPO
T: -
FT: IPO
A: 12000000
MR: -
FA: 12.0 million
FAN: 12000000
D: 2025-04-11
FD: 2025-04-11
-
3 RT: Initial Public Offering
T: -
FT: Initial Public Offering
A: 12000000
MR: -
FA: $12 million
FAN: 12000000
D: 2025-04-10
FD: 2025-04-10
1 investors
4 RT: Initial Public Offering (IPO)
T: -
FT: Initial Public Offering (IPO)
A: 12000000
MR: -
FA: $12 million
FAN: 12000000
D: 2025-04-10
FD: 2025-04-10
-
IPO Latest
2025-05-08
$13.8M
1 investor (Pro only)
IPO 2025-04-11
$12.0M
Initial Public Offering 2025-04-10
$12.0M

View 3 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

D

David Quek

Chief Executive Officer

N

Naresh Waran

Head of R&D

J

Jey Chan

Chief Financial Officer

C

Carl Baptista

Co-Founder & Chief Technology Officer

View 1 more team members with Pro

Unlock Full Team Directory

Recent News

Cuprina Holdings Cayman Limited Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Biomedical and Biotechnology
Company Size
~40 employees (est.)
Locations
Singapore

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro